ROLE OF CD44 IN MAINTENANCE OF PANCREATIC STEM CELL/CHEMORESISTANT PHENOTYPE (CD44 AS A POSSIBLE TARGET FOR DRUGS TO TREAT PANCREATIC CANCER)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Freeman,James W.

Funded by

WILLIAM & ELLA OWENS MED RSCH FOUNDATION

Research Start Date

01/01/2017

Status

Inactive

Clinical Care

Cancer

Bioscience Research Panel